Torna al Registre Simple

Long duration of immunotherapy in a STK11 mutated/KRAS wild-type non-small cell lung cancer patient

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorDomingues, I.
dc.contributor.authorCedres Perez, Susana
dc.contributor.authorCallejo Perez, Ana
dc.contributor.authorVivancos Prellezo, Ana
dc.contributor.authorMartínez Marti, Alexandre
dc.contributor.authorFelip Font, Enriqueta
dc.date.accessioned2021-10-28T09:34:00Z
dc.date.available2021-10-28T09:34:00Z
dc.date.issued2020-01
dc.identifier.citationDomingues I, Cedres S, Callejo A, Vivancos A, Martinez-Marti A, Felip E. Long duration of immunotherapy in a STK11 mutated/KRAS wild-type non-small cell lung cancer patient. Pulmonology. 2019 Jan;26(1):49–50.
dc.identifier.issn2531-0437
dc.identifier.urihttps://hdl.handle.net/11351/6479
dc.descriptionCàncer de pulmó; Immunoteràpia
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesPulmonology;26(1)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectPulmons - Càncer - Immunoteràpia
dc.subject.meshCarcinoma, Non-Small-Cell Lung
dc.subject.mesh/therapy
dc.titleLong duration of immunotherapy in a STK11 mutated/KRAS wild-type non-small cell lung cancer patient
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.pulmoe.2019.05.002
dc.subject.decscarcinoma de pulmón de células no pequeñas
dc.subject.decs/terapia
dc.relation.publishversionhttps://doi.org/10.1016/j.pulmoe.2019.05.002
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Domingues I] Medical Oncology Department, Portuguese Institute of Oncology of Coimbra, Coimbra, Portugal. [Cedres S, Callejo A, Martinez-Marti A, Felip E] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Vivancos A] Cancer Genomics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
dc.identifier.pmid31401029
dc.identifier.wos000505089100008
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail
Name:
long_duration_immunotherapy_st ...
Grandària:
369.8Kb
Format:
PDF
Description:
Long duration of immunotherapy ...
Visualitza

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple